CA3000400C - Anticorps agonistes se liant de maniere specifique au cd40 humain et procedes d'utilisation - Google Patents
Anticorps agonistes se liant de maniere specifique au cd40 humain et procedes d'utilisationInfo
- Publication number
- CA3000400C CA3000400C CA3000400A CA3000400A CA3000400C CA 3000400 C CA3000400 C CA 3000400C CA 3000400 A CA3000400 A CA 3000400A CA 3000400 A CA3000400 A CA 3000400A CA 3000400 C CA3000400 C CA 3000400C
- Authority
- CA
- Canada
- Prior art keywords
- antibody
- seq
- human
- antibodies
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
La présente invention concerne des anticorps antagonistes se liant spécifiquement au CD40 humain, des polynucléotides codant les anticorps ou des fragments se liant à l'antigène, et des procédés de fabrication et d'utilisation de ceux-ci.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562234812P | 2015-09-30 | 2015-09-30 | |
| US62/234,812 | 2015-09-30 | ||
| PCT/US2016/054764 WO2017059243A2 (fr) | 2015-09-30 | 2016-09-30 | Anticorps agonistes se liant de manière spécifique au cd40 humain et procédés d'utilisation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3000400A1 CA3000400A1 (fr) | 2017-04-06 |
| CA3000400C true CA3000400C (fr) | 2025-11-18 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016331819B2 (en) | Agonistic antibodies specifically binding human CD40 and methods of use | |
| US20250215079A1 (en) | Antibodies specifically binding pd-1, tim-3 or pd-1 and tim-3 and their uses | |
| US20230340155A1 (en) | Antibodies that Specifically Bind PD-1 and Methods of Use | |
| US11130802B2 (en) | Anti-lap antibody variants | |
| CA3000400C (fr) | Anticorps agonistes se liant de maniere specifique au cd40 humain et procedes d'utilisation |